This whale alert can help traders discover the next big trading opportunities. Whales are entities w

Stocks fell and small caps slumped Wednesday as the 30-year Treasury yield hit 5.7%, a 24-year high,

Amazon, Alphabet and Tesla rose Friday, but Robinhood traders sold all three. The monthly data sugge

Summit is teaming up with AstraZeneca and Daiichi to test ivonescimab with Datroway across breast an

Summit Therapeutics Inc. (NASDAQ: SMMT) today announced the successful closing of AstraZeneca's (LSE

MIAMI--(BUSINESS WIRE)--Summit Therapeutics Inc. (NASDAQ: SMMT) today announced the successful closi

AstraZeneca & Daiichi Sankyo team up with Summit Therapeutics to test Datroway + ivonescimab com

Summit Therapeutics Inc. (Nasdaq: SMMT) today announced a clinical trial collaboration agreement wit

Collaboration Intends to Evaluate Ivonescimab in Combination with Datroway across Multiple Tumor Typ

MIAMI--(BUSINESS WIRE)--Summit Therapeutics Inc. (Nasdaq: SMMT) today announced a clinical trial col

TOKYO--(BUSINESS WIRE)--Daiichi Sankyo (TSE: 4568) and AstraZeneca (LSE/STO/NYSE: AZN) have entered

Robinhood traders just recorded their biggest five-day buying binge ever, piling into stocks includi

Barclays analyst Etzer Darout maintains Summit Therapeutics (NASDAQ:SMMT) with a Equal-Weight and

Summit Therapeutics PLC (NASDAQ: SMMT - Get Free Report)'s stock price gapped up prior to trading on

Nasdaq 100 gains as softer PCE inflation cools Fed rate-hike bets, with oil above $91 and Micron ear

AstraZeneca just locked in a price to own 12% of Summit Therapeutics that the open market refuses to

Citigroup analyst Yigal Nochomovitz maintains Summit Therapeutics (NASDAQ:SMMT) with a Buy and ra

SMMT shares jump as AstraZeneca commits $2 billion to accelerate ivonescimab development and expand

Summit Therapeutics (SMMT), which holds rights to the cancer drug ivonescimab in major markets outsi

AstraZeneca Plc (NYSE:AZN) on Tuesday agreed to invest $2 billion in newly issued equity in Summit T

AstraZeneca buys $2 billion in Summit Therapeutics equity to test ivonescimab with ADCs, providing c

Gainers Silexion Therapeutics (NASDAQ:SLXN) shares rose 26.8% to $0.32 during Tuesday's pre-mar

Summit Therapeutics shares surged more than 20% in pre-market trading on Tuesday after AstraZeneca a

Navitas jumped 11.8% after winning a U.S. 10kV SiC program; BIO-key led gainers, while NewGenIvf and

AstraZeneca PLC (LSE:AZN, NASDAQ:AZN), the FTSE 100 pharmaceutical company, will invest $2 billion i

Summit shares surged in after-hours trading following the news of AstraZeneca's investment, as the t

Summit Therapeutics said on Monday that British drugmaker AstraZeneca would invest $2 billion in ​th

https://www.astrazeneca.com/media-centre/press-releases/2026/astrazeneca-announces-equity-investment

MIAMI--(BUSINESS WIRE)--Summit Therapeutics Inc. (Nasdaq: SMMT) today announced key developments imp

HC Wainwright & Co. analyst Mitchell S. Kapoor reiterates Summit Therapeutics (NASDAQ:SMMT) f

This whale alert can help traders discover the next big trading opportunities. Whales are entities w

Data from the Phase III HARMONi-GI1 trial, conducted in China and sponsored by Akeso, Inc., featurin

MIAMI--(BUSINESS WIRE)--Summit Therapeutics Inc. (Nasdaq: SMMT) today noted that data from the Phase

A fourth straight decline in crude oil handed Wall Street a fresh leg higher Monday, with the Nasdaq

This whale alert can help traders discover the next big trading opportunities. Whales are entities w

Updated overall survival (OS) results from the global Phase III HARMONi clinical trial featuring the

MIAMI--(BUSINESS WIRE)--Summit Therapeutics Inc. (Nasdaq: SMMT) announced that updated overall survi

Summit partner Akeso reports 30.8-month median OS for ivonescimab vs 22.6 for pembrolizumab in lung

Ivonescimab Reduced the Risk of Death by 27% Compared to PembrolizumabHARMONi-2 Demonstrated an Impr

Summit Therapeutics Inc. (NASDAQ: SMMT) today noted that its partner Akeso Inc. [url="]announced[/ur

MIAMI--(BUSINESS WIRE)---- $SMMT--Summit Therapeutics Inc. (NASDAQ: SMMT) today noted that its partn

Jefferies analyst Faisal Khurshid upgrades Summit Therapeutics (NASDAQ:SMMT) from Hold to Buy and

Stocks rallied and Treasury yields retreated from three-year highs after Fed Governor Waller signale

Summit Therapeutics' partner Akeso reported positive overall survival results for ivonescimab in

U.S. stocks rose Thursday; Summit Therapeutics jumped 10.1% after Phase III results, while Snowflake

Summit Therapeutics Inc. (NASDAQ:SMMT) today noted that its partner Akeso Inc. announced positive ov

Summit Therapeutics partner Akeso Phase 3 HARMONi-GI1 trial shows ivonescimab outperforms durvalumab

Nasdaq 100 falls 0.6% as traders wait on Nvidia and hot July PCE revives September rate-hike bets. E

U.S. stocks mixed, Nasdaq up 0.1%. Abercrombie & Fitch shares surge 31.6% after beating earnings

Gainers Nuwellis (NASDAQ:NUWE) stock increased by 27.2% to $1.22 during Wednesday's pre-market